Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: dose 1 Johnson and Johnson/ dose 2 BNT162B2/ dose 3 BNT162B2; dose 1 Johnson and Johnson/ dose 2 BNT162B2/ dose 3 BNT162B2; surgery is for right knee replacement; Pfizer COVID-19 Vaccine Gray Cap was administered after the refrigeration conditions (2 to 8°C)/ BUD was on 05May2022 then administered on 11May2022; Pfizer COVID-19 Vaccine Gray Cap was administered after the refrigeration conditions (2 to 8°C)/ BUD was on 05May2022 then administered on 11May2022; This is a spontaneous report received from contactable reporter (Nurse) from medical information team, Program ID: (159558).  A 79-year-old female patient received BNT162b2 (BNT162B2), on 11May2022 at 08:30 as dose 3 (booster), 0.3 ml single (Lot number: FP4554) at the age of 79 years intramuscular, in right deltoid for COVID-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Janssen COVID-19 vaccine (dose 1, single, Manufacturer: Johnson and Johnson, LOT: 1802068 , EXP: Unknown, Dose and Route: 0.5, route unknown), administration date: 25Mar2021, when the patient was 78-year-old, for COVID-19 immunization; BNT162b2 (dose 2, single, Manufacturer: Pfizer , LOT: FE3590, EXP: Unknown, Dose and Route: 0.3; route unknown), administration date: 01Nov2021, when the patient was 79-year-old, for COVID-19 immunization. The following information was reported: POOR QUALITY PRODUCT ADMINISTERED (non-serious), PRODUCT ADMINISTRATION ERROR (non-serious) all with onset 11May2022 at 08:30, outcome "unknown" and all described as "Pfizer COVID-19 Vaccine Gray Cap was administered after the refrigeration conditions (2 to 8°C)/ BUD was on 05May2022 then administered on 11May2022"; OFF LABEL USE (medically significant), INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown" and all described as "dose 1 Johnson and Johnson/ dose 2 BNT162B2/ dose 3 BNT162B2"; KNEE ARTHROPLASTY (medically significant), outcome "unknown", described as "surgery is for right knee replacement".  Additional information: Pfizer COVID-19 Vaccine Gray Cap was administered after the refrigeration conditions (2 to 8°C). The BUD (beyond use date) was on 05May2022. They were supposed to stop giving vaccines on 05May2022, which was the last day of ten weeks for the vaccine but administered on 11May2022. The patient was at facility for pre-op. The patient hasn't for surgery yet, surgery is for right knee replacement on 20Jun2022.; Sender's Comments: There is not a reasonable possibility that the event right knee replacement was related to the vaccination of BNT162B2 in this elderly patient based on the available information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-202200794018 same reporter/drug, similar events, different patients;US-PFIZER INC-202200789684 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794015 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794019 same reporter/drug, similar events, different patients;US-PFIZER INC-202200789683 same reporter/drug, similar events, different patients;US-PFIZER INC-202200793996 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794014 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794001 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794003 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794006 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794007 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794002 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794013 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794008 same reporter/drug, similar events, different patients;US-PFIZER INC-202200793995 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794010 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794016 same reporter/drug, similar events, different patients;US-PFIZER INC-202200793997 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794004 same reporter/drug, similar events, different patients;US-PFIZER INC-202200789685 same reporter/drug, similar events, different patients;US-PFIZER INC-202200793998 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794005 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794011 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794020 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794009 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794017 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794000 same reporter/drug, similar events, different patients;US-PFIZER INC-202200794012 same reporter/drug, similar events, different patients;US-PFIZER INC-202200793999 same reporter/drug, similar events, different patients